A 2023 review in Obesity noted that dual-therapy users reported higher rates of these adverse events compared to monotherapy groups
therefore, although we have shown HbA1c and weight improvements in cohorts switching to semaglutide, these patients may have switched treatment for various reasons other than glycaemic control and weight loss
In rare cases, they might cause mild digestive issues like upset stomach or diarrhoea
Opportunistic pathogens including Clostridium hathewayi , Clostridium symbiosum , Clostridium ramosum , Bacteroides caccae , Eggerthella lenta and E
Your doctor's office will typically submit a request to Blue Cross Blue Shield, providing medical records and justification for the medication
The mitochondrial signalling pathway of intrinsic apoptosis is particularly relevant to the pathogenesis of vitiligo (Fig